Efficacy and Safety of Methotrexate in Combination with Mini Pulse Doses of Methylprednisolone in Severe Alopecia Areata. The Vietnamese Experience
DOI:
https://doi.org/10.3889/oamjms.2019.004Keywords:
Alopecia areata, Methotrexate, Mini-pulse dose, Alopecia areata totalis, Alopecia areata universalisAbstract
BACKGROUND: Treatment of severe alopecia areata remains very difficult, especially in alopecia areata totalis and alopecia areata universalis. Methotrexate is known to be effective in the treatment of severe and chronic autoimmune disorders.
OBJECTIVE: To assess the effectiveness and safety of MTX in combination with mini pulse dose of methylprednisolone in the treatment of severe alopecia areata.
PATIENTS AND METHODS: The open, uncontrolled study compared pre-treatment and after-treatment. Thirty-eight patients (age 16-64) with severity AA (SALT score > 50 %) visiting National hospital of Dermatology and Venereology from April-2004 to September-2015 were enrolled. All patients received oral methylprednisolone 24mg/day for 3 consecutive days of a week in combination with oral MTX 7,5 mg weekly. This regimen is maintained up to 12 weeks and follow-up until to 6 months.
RESULTS: After 6 months, 60.5% of patients show complete hair growth (good response) and 18.4% shows the medium response. There is a significant SALT score reduction: mean baseline SALT score 84.39 ± 17.03 compared to mean post-treatment SALT score 24.19 ± 29.42. Good clinical improvement noted in after 3 months. We do not observe any side- effects related to oral MTX and oral methylprednisolone, and no patients had to withdrawal treatment due to side- effects.
CONCLUSION: Combination Methotrexate and mini pulse dose of methylprednisolone are effective and safe in treatment severity alopecia areata.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Mitchell AJ, Krull EA. Alopecia areata: pathogenesis and treatment. Journal of the American Academy of Dermatology. 1984; 11(5):763-75. https://doi.org/10.1016/S0190-9622(84)80450-8 DOI: https://doi.org/10.1016/S0190-9622(84)80450-8
Hedstrand H, Ekwall O, Michaëlsson G, Rorsman F, Kämpe O, Perheentupa J, Gustafsson J, Husebye E. Antibodies against hair follicles are associated with alopecia totalis in autoimmune polyendocrine syndrome type I. Journal of investigative dermatology. 1999; 113(6):1054-8. https://doi.org/10.1046/j.1523-1747.1999.00778.x PMid:10594751 DOI: https://doi.org/10.1046/j.1523-1747.1999.00778.x
Olsen EA, Hordinsky MK, Price VH, Roberts JL, Shapiro J, Canfield D, Duvic M, King LE, McMichael AJ, Randall VA, Turner ML. Alopecia areata investigational assessment guidelines–Part II. Journal of the American Academy of Dermatology. 2004; 51(3):440-7. https://doi.org/10.1016/j.jaad.2003.09.032 PMid:15337988 DOI: https://doi.org/10.1016/j.jaad.2003.09.032
Alkhalifah A, Alsantali A, et al. Alopecia areata update. Journal of the American Academy of Dermatology. 2010; 62(2):191-202. https://doi.org/10.1016/j.jaad.2009.10.031 PMid:20115946 DOI: https://doi.org/10.1016/j.jaad.2009.10.031
McDonagh AJ, Taziâ€Ahnini R. Epidemiology and genetics of alopecia areata. Clinical and Experimental Dermatology: Clinical dermatology. 2002; 27(5):405-9. https://doi.org/10.1046/j.1365-2230.2002.01077.x PMid:12190641 DOI: https://doi.org/10.1046/j.1365-2230.2002.01077.x
Alzolibani AA. Epidemiologic and genetic characteristics of alopecia areata (part 1). Acta Dermatoven APA. 2011; 20(4):191-8.
Alzolibani AA, Zari S, et al. Epidemiologic and genetic characteristics of alopecia areata (part 2). Acta Dermatovenerol Alp Pannonica Adriat. 2012; 21(1):15-19.
Yang S, Yang J, Liu JB, Wang HY, Yang Q, Gao M, Liang YH, Lin GS, Lin D, Hu XL, Fan L. The genetic epidemiology of alopecia areata in China. British Journal of Dermatology. 2004; 151(1):16-23. https://doi.org/10.1111/j.1365-2133.2004.05915.x PMid:15270868 DOI: https://doi.org/10.1111/j.1365-2133.2004.05915.x
Xiao FL, Yang S, Liu JB, He PP, Yang J, Cui Y, Yan KL, Gao M, Liang YH, Zhang XJ. The epidemiology of childhood alopecia areata in China: a study of 226 patients. Pediatric dermatology. 2006; 23(1):13-8. https://doi.org/10.1111/j.1525-1470.2006.00161.x PMid:16445403 DOI: https://doi.org/10.1111/j.1525-1470.2006.00161.x
Unger WP. Systemic corticosteroids in alopecia totalis. Canadian Medical Association Journal. 1973; 108(2):177-180. PMid:4684625 PMCid:PMC1941146
Tosti A, Guidetti MS, Bardazzi F, Misciali C. Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis. Journal of the American Academy of Dermatology. 1996; 35(2):199-201. https://doi.org/10.1016/S0190-9622(96)90323-0 DOI: https://doi.org/10.1016/S0190-9622(96)90323-0
Bajaj DR, Devrajani BR, Shah SZ, Ghauri RA, Matlani BL. Treatment of extensive alopecia areata with oral prednisolone mini-pulse regimen. Journal of Pakistan Association of Dermatology. 2016; 18(4):226-31.
Harries MJ, Sun J, et al. Management of alopecia areata. Bmj. 2010; 341(1):c3671-c3671. https://doi.org/10.1136/bmj.c3671 PMid:20656774 PMCid:PMC3230136 DOI: https://doi.org/10.1136/bmj.c3671
Michalowski R. Alopecia areata totalis/universalis and systemic corticosteroids. International journal of dermatology. 1999; 38(12):947. PMid:10671096
MacDonald Hull SP, Wood ML, Hutchinson PE, Sladden M, Messenger AG. Guidelines for the management of alopecia areata. British Journal of Dermatology. 2003; 149(4):692-9. https://doi.org/10.1046/j.1365-2133.2003.05535.x PMid:14616359 DOI: https://doi.org/10.1046/j.1365-2133.2003.05535.x
Zargari O, Hejazi S, Shahidiâ€Dadras M, Younespour S, Robati R, Firooz A, Toosi P, Feldman SR. Considerable variation among I ranian dermatologists in the dosing and monitoring of methotrexate for treating psoriasis. International journal of dermatology. 2014; 53(3):385-9. https://doi.org/10.1111/ijd.12201 PMid:24134730 DOI: https://doi.org/10.1111/ijd.12201
Joly P. The use of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia totalis or universalis. Journal of the American Academy of Dermatology. 2006; 55(4):632-6. https://doi.org/10.1016/j.jaad.2005.09.010 PMid:17010743 DOI: https://doi.org/10.1016/j.jaad.2005.09.010
Chartaux E, Joly P. Long-term follow-up of the efficacy of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia areata totalis or universalis. InAnnales de dermatologie et de venereologie. 2010; 137(8-9):507-513.
Royer M, Bodemer C, Vabres P, Pajot C, Barbarot S, Paul C, Mazereeuw J. Efficacy and tolerability of methotrexate in severe childhood alopecia areata. British Journal of Dermatology. 2011; 165(2):407-10. https://doi.org/10.1111/j.1365-2133.2011.10383.x PMid:21517797 DOI: https://doi.org/10.1111/j.1365-2133.2011.10383.x
Firooz AR, Fouladi DF. Methotrexate Plus Prednisolone in Severe Alopecia Areata. American Journal of Drug Discovery and Development. 2013; 3: 188-193. https://doi.org/10.3923/ajdd.2013.188.193 DOI: https://doi.org/10.3923/ajdd.2013.188.193
Tosti A, Piraccini BM, Pazzaglia M, Vincenzi C. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis. Journal of the American Academy of Dermatology. 2003; 49(1):96-8. https://doi.org/10.1067/mjd.2003.423 PMid:12833016 DOI: https://doi.org/10.1067/mjd.2003.423
Choi HJ, Ihm CW. Acute alopecia totalis. Acta Dermatovenerol Alp Pannonica Adriat. 2006; 15(1):27-34.
Shaheedi-Dadras M, Karami A, Mollaei F, Moravvej H, Malekzad F. The effect of methylprednisolone pulse-therapy plus oral cyclosporine in the treatment of alopecia totalis and universalis. Arch Iran Med. 2008; 11(1):90-3. PMid:18154427
Droitcourt C, Milpied B, Ezzedine K, Hubiche T, Belin E, Akpadjan F, Taïeb A, Seneschal J. Interest of high-dose pulse corticosteroid therapy combined with methotrexate for severe alopecia areata: a retrospective case series. Dermatology. 2012; 224(4):369-73. https://doi.org/10.1159/000339341 PMid:22738995 DOI: https://doi.org/10.1159/000339341
Alsantali A. Alopecia areata: a new treatment plan. Clinical, cosmetic and investigational dermatology. 2011; 4:107. https://doi.org/10.2147/CCID.S22767 PMid:21833161 PMCid:PMC3149478 DOI: https://doi.org/10.2147/CCID.S22767
Garg S, Messenger AG. Alopecia areata: evidence-based treatments. 2009; 28(1):15-8. DOI: https://doi.org/10.1016/j.sder.2008.12.002
Farshi S, Mansouri P, Safar F, Khiabanloo SR. Could azathioprine be considered as a therapeutic alternative in the treatment of alopecia areata? A pilot study. International journal of dermatology. 2010; 49(10):1188-93. https://doi.org/10.1111/j.1365-4632.2010.04576.x PMid:20883409 DOI: https://doi.org/10.1111/j.1365-4632.2010.04576.x
Gianfaldoni S, Tchernev G, Wollina U, Lotti T. A Case of Alopecia Areata in a Patient with Turner Syndrome. Open Access Maced J Med Sci. 2017; 5(4):493-496. https://doi.org/10.3889/oamjms.2017.127 PMid:28785342 PMCid:PMC5535667 DOI: https://doi.org/10.3889/oamjms.2017.127
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Anh Tran Thi Van, Anh Tran Lan, Minh Ha Anh, Thuong Nguyen Van, Phuong Pham Thi Minh, Trang Trinh Minh, Nghi Dinh Huu, Tung Vu Thanh, My Le Huyen, Khang Tran Hau, Marco Gandolfi, Francesca Satolli, Claudio Feliciani, Michael Tirant, Aleksandra Vojvodic, Torello Lotti
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0)
